Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?

Keytruda, a case study for the improved regulatory environment in China

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Planning for Competition in Launch Strategy

Orphan Disease Drug Sales – How Much Opportunity is There by Region?

SHIFTING TIDES IN PHARMA DEALMAKING

Stakeholder Engagement Strategies in Launch Planning

The Year That Was: Oncology Edition

Highlights from AAO 2018: Changes in the Management of Retinal Conditions on the Horizon

Drug Launch Performance

Major Themes from Meeting on the Mesa 2018

The Medicines Optimisation Program in England

OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology

Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles

Commercial and Developmental Innovation: What Can We Learn from Gene Therapies?

Health Advances Blog

Category: BioPharma

Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?

Keytruda, a case study for the improved regulatory environment in China

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Planning for Competition in Launch Strategy

Orphan Disease Drug Sales – How Much Opportunity is There by Region?

SHIFTING TIDES IN PHARMA DEALMAKING

Stakeholder Engagement Strategies in Launch Planning

The Year That Was: Oncology Edition

Highlights from AAO 2018: Changes in the Management of Retinal Conditions on the Horizon

Drug Launch Performance

Major Themes from Meeting on the Mesa 2018

The Medicines Optimisation Program in England

OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology

Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles

Commercial and Developmental Innovation: What Can We Learn from Gene Therapies?